# US 2026/0125689 A1 · Novel Nuclear Localization Sequence Mutant and Method for Improving Biosynthetic Efficiency Using Same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0125689 A1
- Document ID: US20260125689A1
- Status: Published application
- Kind: A1
- Application number: 19/426,208
- Filed: 2025-12-19
- Published: 2026-05-07
- Earliest claimed: 2025-06-24
- Assignees: Jiangnan University
- Applicants: Jiangnan University
- Inventors: Ye LI; Zhonghu BAI; Zhenhao FU; Pingxin LIN
- Web page: https://patentgrep.com/patent/US20260125689A1

## CPC

- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 9/001: {acting on the CH-CH group of donors (1.3)}
- C12N 9/0028: {with NAD or NADP as acceptor (1.5.1)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/1085: {transferring alkyl or aryl groups other than methyl groups (2.5)}
- C12N 9/90: Isomerases (5.)
- C12N 9/93: {Ligases (6)}
- C12P 7/22: aromatic
- C12P 17/06: containing a six-membered hetero ring, e.g. fluorescein
- C12Y 103/01012: Prephenate dehydrogenase (1.3.1.12)
- C12Y 114/14009: 4-Hydroxyphenylacetate 3-monooxygenase (1.14.14.9)
- C12Y 205/01054: 3-Deoxy-7-phosphoheptulonate synthase (2.5.1.54)
- C12Y 504/99005: Chorismate mutase (5.4.99.5)
- C12Y 604/01002: Acetyl-CoA carboxylase (6.4.1.2)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

Disclosed are a novel nuclear localization sequence (NLS) mutant and a method for improving biosynthetic efficiency using same, belonging to the field of bioengineering. According to the present disclosure, a novel NLS is screened out, and recombinant yeast with improved metabolite synthesis efficiency is constructed by applying the NLS obtained through screening, which provides key technical support for developing a high-yield, stable and cost-effective yeast biosynthesis platform, and facilitates the use of recombinant yeast as a cell factory for large-scale industrial biomanufacturing.

## Claims

### Claim 1

A nuclear localization sequence (NLS), wherein the nucleotide sequence of the NLS is set forth in SEQ ID NO: 1.

### Claim 2 (depends on 1)

A biological material comprising the NLS according to claim 1.

### Claim 3 (depends on 2)

The biological material according to claim 2, wherein the biological material is a nucleic acid construct.

### Claim 4 (depends on 3)

The biological material according to claim 3, wherein the nucleic acid construct comprises at least one NLS and at least one gene related to a biological metabolic pathway; and the NLS is linked upstream or downstream of the gene related to the biological metabolic pathway for guiding a directional localization of a gene expression product to a host cell nucleus.

### Claim 5 (depends on 4)

The biological material according to claim 4, wherein a protein encoded by the gene related to the biological metabolic pathway is involved in a synthetic pathway of a target metabolite in a microorganism.

### Claim 6 (depends on 4)

The biological material according to claim 4, wherein the host is a eukaryotic microorganism; and the eukaryotic microorganism comprises Saccharomyces cerevisiae.

### Claim 7 (depends on 2)

The biological material according to claim 2, wherein the biological material is recombinant S. cerevisiae, comprising a gene localized under the guidance of the NLS.

### Claim 8 (depends on 7)

The biological material according to claim 7, comprising any one of (a) to (c):
(a) the recombinant S. cerevisiae comprises an Acc1 gene with a nucleotide sequence as set forth in SEQ ID NO: 3 and a 2-Pyrone synthase (Gh2-PS) gene with a nucleotide sequence set forth in SEQ ID NO: 4, and 3′ ends of the Acc1 gene and the Gh2-PS gene are separately linked to the NLS;
(b) the recombinant S. cerevisiae comprises the Acc1 gene with the nucleotide sequence set forth in SEQ ID NO: 3 and an RppA gene with the nucleotide sequence as set forth in SEQ ID NO: 10, and 3′ ends of the Acc1 gene and the RppA gene are separately linked to the NLS; and
(c) the recombinant S. cerevisiae comprises an ARO4 gene with the nucleotide sequence set forth in SEQ ID NO: 5, an ARO7 gene with the nucleotide sequence set forth in SEQ ID NO: 6, a TyrA gene with the nucleotide sequence as set forth in SEQ ID NO: 7, a PaHpaB gene with the nucleotide sequence as set forth in SEQ ID NO: 8 and an EcHpaC gene with the nucleotide sequence as set forth in SEQ ID NO: 9, and 3′ ends of the ARO4 gene, the ARO7 gene, the TyrA gene, the PaHpaB gene and the EcHpaC gene are separately linked to the NLS.

### Claim 9

A method for improving biosynthetic efficiency, comprising following steps:
(a) constructing a recombinant nucleic acid construct, wherein the construct comprises: at least one nuclear localization sequence (NLS), and at least one gene encoding a key enzyme in a synthetic pathway of a target metabolite; the NLS is operably linked upstream or downstream of the gene; and the nucleotide sequence of the NLS is set forth in SEQ ID NO: 1;
(b) introducing the recombinant nucleic acid construct in (a) into a eukaryotic microbial host cell;
(c) culturing the host cell in (b) under suitable conditions to enable the expression and localization of the key enzyme within a cell nucleus; and
(d) collecting the target metabolite.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the target metabolite comprises products of the metabolic pathways of triacetic acid lactone (TAL), mevalonic acid (MVA), tryptophol, methyl anthranilate (Me-AA), 2-phenylethanol (2-PE), tyrosol, or hydroxytyrosol (HT).
